Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Up 6.9% in January

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) was the recipient of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 3,100 shares, a growth of 6.9% from the January 15th total of 2,900 shares. Based on an average daily trading volume, of 11,900 shares, the days-to-cover ratio is currently 0.3 days.

Invesco Nasdaq Biotechnology ETF Price Performance

NASDAQ:IBBQ opened at $22.58 on Tuesday. Invesco Nasdaq Biotechnology ETF has a one year low of $20.14 and a one year high of $24.84. The company has a market cap of $39.97 million, a PE ratio of 17.39 and a beta of 0.61. The firm has a 50-day moving average of $22.09 and a 200-day moving average of $23.11.

Invesco Nasdaq Biotechnology ETF Announces Dividend

The business also recently announced a dividend, which was paid on Friday, December 27th. Stockholders of record on Monday, December 23rd were issued a $0.0619 dividend. The ex-dividend date of this dividend was Monday, December 23rd.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of IBBQ. Mirae Asset Global Investments Co. Ltd. lifted its stake in Invesco Nasdaq Biotechnology ETF by 22.7% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 259,733 shares of the company’s stock valued at $6,156,000 after acquiring an additional 48,137 shares in the last quarter. Strategic Financial Concepts LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF during the fourth quarter valued at about $1,699,000. Raymond James Financial Inc. purchased a new position in Invesco Nasdaq Biotechnology ETF during the fourth quarter worth about $888,000. Advisory Services Network LLC boosted its holdings in Invesco Nasdaq Biotechnology ETF by 5.8% during the fourth quarter. Advisory Services Network LLC now owns 53,609 shares of the company’s stock worth $1,154,000 after purchasing an additional 2,922 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its position in Invesco Nasdaq Biotechnology ETF by 148.5% in the 4th quarter. Tower Research Capital LLC TRC now owns 28,061 shares of the company’s stock worth $604,000 after purchasing an additional 16,768 shares in the last quarter.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.